Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biodroga Nutraceutical is a specialized contract development and manufacturing organization (CDMO) focused on the natural health products and dietary supplement industries. Based in Quebec, Canada, the company provides comprehensive services including custom formulation, encapsulation, and packaging for a wide range of products such as omega-3 oils, probiotics, and vitamins. They are particularly recognized for their expertise in softgel technology and liquid filling capabilities. In 2023, Biodroga was acquired by Lallemand, a global leader in yeast and bacteria production, to strengthen its position in the health and nutrition market. The company continues to operate as a key provider of high-quality manufacturing solutions for global supplement brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biodroga Nutraceutical.